The extracellular application of ENO1 recombinant proteins reduced the EdU-based proliferation and transwell invasion of mammary tumor cells, and it downregulated Lrp5, MMP9, Runx2, TGFβ, and Snail 6. Here, TGFB1 is linked to breast cancer.